KRMD
KORU Medical Systems, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$3.25
+0.93%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 45.1M | 41.1M | 33.6M | 28.5M | 27.9M |
| Cost of Revenue | 17.1M | 15.5M | 12.3M | 11.8M | 12.5M |
| Gross Profit | 28.0M | 25.6M | 21.3M | 16.7M | 15.4M |
| Operating Expenses | |||||
| R&D Expense | 4.5M | 4.4M | 5.3M | 5.7M | 5.0M |
| SG&A Expense | 24.6M | 23.4M | — | — | — |
| General & Admin Expense | 5.9M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 593.7K | 810.5K | 22.5M | 21.2M | 21.2M |
| Total Operating Expenses | 29.6M | 28.6M | 27.8M | 27.0M | 26.1M |
| Cost and Expenses | 46.8M | 44.1M | 40.1M | 38.8M | 38.7M |
| Operating Income (EBIT) | (1.7M) | (3.0M) | (6.4M) | (10.3M) | (10.8M) |
| Non-Operating | |||||
| Interest Income | 282.1K | 293.4K | 444.6K | 561.3K | 145.6K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 282.1K | 293.4K | 444.6K | 561.3K | 145.6K |
| Other Non-Op Income/Expense | (156.4K) | 356.4K | 382.5K | 496.4K | 105.7K |
| Non-Operating Income (excl Interest) | 156.4K | (356.4K) | (382.5K) | (496.4K) | (105.7K) |
| EBT (Pre-Tax Income) | (1.8M) | (2.6M) | (6.1M) | (9.8M) | (10.7M) |
| Income Tax Expense | 10.3K | 21.9K | 2.9K | 4.0M | (2.0M) |
| Bottom Line | |||||
| Net Income | (1.8M) | (2.6M) | (6.1M) | (13.7M) | (8.7M) |
| Earnings from Cont. Ops | (1.8M) | (2.6M) | (6.1M) | (13.7M) | (8.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (1.8M) | (2.6M) | (6.1M) | (13.7M) | (8.7M) |
| Per Share | |||||
| Basic EPS | ($0.04) | ($0.06) | ($0.13) | ($0.30) | ($0.19) |
| Diluted EPS | ($0.04) | ($0.06) | ($0.13) | ($0.30) | ($0.19) |
| Revenue Per Share | $0.98 | $0.89 | $0.73 | $0.63 | $0.62 |
| Shares | |||||
| Basic Shares Outstanding | 46.1M | 46.2M | 45.8M | 45.6M | 45.0M |
| Diluted Shares Outstanding | 49.5M | 46.2M | 45.8M | 45.6M | 45.0M |
| Profitability Metrics | |||||
| EBITDA | (1.0M) | (1.8M) | (5.3M) | (8.9M) | (10.1M) |
| D&A | 791.2K | 810.5K | 772.9K | 870.4K | 587.1K |
| EBIT | (1.8M) | (2.6M) | (6.1M) | (9.8M) | (10.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026